AMI
Clinical trials for AMI explained in plain language.
Never miss a new study
Get alerted when new AMI trials appear
Sign up with your email to follow new studies for AMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: AMI
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 17, 2026 07:35 UTC
-
Oxygen therapy after heart attack may cut heart failure risk
Disease control Recruiting nowThis study follows 1000 heart attack patients to see if adding SuperSaturated Oxygen therapy to standard artery-opening treatment reduces the chance of heart failure or death within a year. Participants are adults who had a specific type of heart attack and successful artery repa…
Matched conditions: AMI
Sponsor: TherOx • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a diabetes pill mend hearts after a heart attack?
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help prevent further heart damage in people who have had a major heart attack. About 450 adults with weakened heart pumping function will receive either the drug or a placebo for 6 mon…
Matched conditions: AMI
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC